InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the detailed record of transactions filed by Rolke James. Director active across 1 company, notably Revelation Biosciences, INC.. Aggregated, 6 filings have been logged. History available since 11 February 2025. The latest transaction was filed on 17 August 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
Rolke James is a declarant with 6 filings in total. The sampled recent filings, all linked to Revelation Biosciences, INC., cover the period from 2025-02-13 to 2026-08-18, with transaction nature shown as Attribution and buy and sell amounts at 0.